Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients

• Main Authors: Can Liu, Nan Zhou, Jieying Li, Jun Kong, Xi Guan, Xudong Wang
• Format: Article
• Language: English
• Published: Hindawi Limited 2017-01-01
• Series: Disease Markers
• Online Access: http://dx.doi.org/10.1155/2017/2176460

Eg5 (kinesin spindle protein) plays an essential role in mitosis. Inhibition of Eg5 function results in cell cycle arrest at mitosis, which leads to cell death. To date, Eg5 expression and its prognostic significance have not been studied in hepatocellular carcinoma (HCC). In this study, 26 freshly frozen HCC tissue samples and matched peritumoral tissue samples were evaluated with a one-step qPCR test and immunohistochemical (IHC) analysis was conducted on 156 HCC samples to investigate the relationships among Eg5 expression, clinicopathological factors, and prognosis. Eg5 mRNA and protein expression levels were significantly higher in HCC tissues relative to matched noncancerous tissues (p<0.05). High Eg5 protein expression was significantly related to liver cirrhosis (p=0.038) and TNM stage (p=0.008). Kaplan-Meier survival and Cox regression analyses revealed that Eg5 overexpression (p=0.001), liver cirrhosis (p=0.009), and TNM stage (p=0.025) were independent prognostic factors for overall survival. These findings indicate that Eg5 expression can be used as a biomarker of poor prognosis and as a novel therapeutic target for HCC.